Inventor · disambiguated record
Judith Altarejos
Also filed as: ALTAREJOS Judith
9 granted patents·6 pending applications·39 citations·filing 2016–2025
86Inventor score
Files withREGENERON PHARMA15
Top patents by PatentIndex Score
15 records- 0194US10618968B2Antigen-binding proteins that activate the leptin receptorREGENERON PHARMA·Filed 2018·Granted Apr 14, 2020·7 cites·34 claims
- 0294US10023644B2Antigen-binding proteins that activate the leptin receptorREGENERON PHARMA·Filed 2016·Granted Jul 17, 2018·14 cites·14 claims
- 0391US11608381B2Methods of treatment using a leptin receptor agonist antibodyREGENERON PHARMA·Filed 2019·Granted Mar 21, 2023·4 cites·9 claims
- 0491US10253102B2Antigen-binding proteins that activate the leptin receptorREGENERON PHARMA·Filed 2018·Granted Apr 9, 2019·7 cites·29 claims
- 0590US11535675B2Antigen-binding proteins that antagonize leptin receptorREGENERON PHARMA·Filed 2020·Granted Dec 27, 2022·2 cites·25 claims
- 0690US10550192B2Antigen-binding proteins that antagonize leptin receptorREGENERON PHARMA·Filed 2017·Granted Feb 4, 2020·4 cites·24 claims
- 0786US2025051465A1Antigen-binding proteins that activate the leptin receptorREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0881US2025320301A1Methods of treatment using a leptin receptor agonist antibodyREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0979US12275792B2Antigen-binding proteins that activate the leptin receptorREGENERON PHARMA·Filed 2021·Granted Apr 15, 2025·0 cites·14 claims
- 1079US11834500B2Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Dec 5, 2023·1 cites·9 claims
- 1177US12371503B2Methods of treatment using a leptin receptor agonist antibodyREGENERON PHARMA·Filed 2022·Granted Jul 29, 2025·0 cites·12 claims
- 1275US2023235068A1Antigen-binding proteins that antagonize leptin receptorREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1374US2024158497A1Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1467US2020031946A1Antigen-binding proteins that activate the leptin receptorREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 1551US2024247071A2Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin AREGENERON PHARMA·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Judith Altarejos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →